Oman issues licence to import Pfizer COVID-19 vaccine
The General Directorate of Pharmacy and Drug Control at Oman’s Ministry of Health has issued a licence to import Pfizer/Bionic COVID-19 vaccine for emergency use to prevent coronavirus.
The Pfizer vaccine is intended for use of people 16 years or older, with people having the choice of taking it or not. The vaccine will have to be taken in two doses over an interval of three weeks. Health Minister Dr Ahmed Al Saeedi had informed during a virtual press conference last week that the vaccine will be available in Oman by the last week of this month.
With the awareness campaigns and the compliance of general public with the measures to curb COVID-19, the numbers had indeed come down since October, it was revealed by Dr Saeedi. The vaccine will be provided on a priority basis and free of cost to the groups most at risk, including front line medical staff, basic service providers, chronic disease patients, and those with compromised immunity levels, at a rate of two doses per person.
Priority will be given to those above the age of 65, those with diabetes, chronic lung diseases, kidney disease, those undergoing dialysis, health workers in intensive care, and workers in the COVID-19 wards.
Oman has undertaken a survey to learn about society’s attitude and acceptability of COVID-19 vaccine, which began yesterday. The survey is expected to bring a deeper understanding among people, thereby striving to eliminate any misconceived notions about the vaccine.